Bio-Path Holdings logo
Bio-Path Holdings BPTH
$ 0.76 -4.82%

Квартальный отчет 2024-Q3
добавлен 14.11.2024

report update icon

Bio-Path Holdings Мультипликаторы 2011-2024 | BPTH

Мультипликаторы по годам Bio-Path Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.2 -0.0 -2.4 -1.4 -2.0 -0.1 -3.3 -12.8 -23.0 -44.6 -95.3 -7.8 -5.7

P/S

- - - - - - 626.7 6631.9 - - - - -

EPS

-33.6 -38.1 -1.6 -2.8 -3.2 -14.4 -0.8 -0.1 -0.1 -0.1 -0.1 -0.0 -0.0

EV (Enterprise Value)

4.67 млн -8.01 млн 2.56 млн 2.93 млн -1.87 млн 1.32 млн 18 млн 80.8 млн 118 млн 188 млн 308 млн 20 млн 12.8 млн

EBITDA per Share

-33 -38 -1.54 -2.91 -3.19 -12.7 -17 -17.8 -11.8 -9.79 -8.71 -8.08 -8

EV/EBITDA

0.2 -0.2 0.4 -0.0 -2.0 -9.3 -22.1 -43.0 -99.0 -8.2 -5.8

PEG

-0.0 -0.0 0.08 -0.11 -0.03 -0.01 0.23 0.77 1.15 2.32 3.81 0.27 0.18

P/B

6.7 0.0 1.0 1.0 0.8 1.0 2.9 10.5 12.8 13.5 65.0 10.0 4.6

P/CF

-0.3 -0.0 -2.5 -1.4 -2.0 -0.2 -2.7 -10.2 -25.1 -51.2 -134.5 -10.0 -10.2

ROE %

-3645.80 -97.84 -41.01 -72.21 -40.78 -704.68 -87.06 -81.92 -55.68 -30.30 -68.27 -128.20 -81.08

ROA %

-499.32 -86.83 -39.30 -66.05 -37.95 -367.58 -79.28 -55.35 -50.83 -29.20 -64.31 -110.19 -73.14

ROCE %

-3592.52 -98.07 -41.02 -71.27 -40.59 -655.34 -111.14 -76.04 -55.86 -30.45 -68.34 -128.20 -81.15

Current Ratio

1.2 8.9 23.9 13.6 17.7 1.7 9.4 10.1 10.2 25.1 12.4 2.3 3.6

DSO

- - - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Bio-Path Holdings

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.7 -1.16 -4.88 - -6.36 -10.64 -13.25 - -0.49 -0.42 -0.47 - -0.29 -0.26 -0.43 - -0.8 -0.55 -0.9 - -0.78 -0.87 -0.89 - -5.38 -2.96 -3.38 - -0.25 -0.31 -0.04 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 - -0.01 -0.01 -0.01 - -0.01 -0.01 -0.01

EBITDA per Share

- -1.87 -5.68 - - - -13.2 - -0.49 -0.41 -0.47 - -0.29 -0.25 -0.42 - -790 -544 -0.9 - -0.75 -0.85 -0.86 - -5.03 -2.73 -3.27 - -0.23 -0.22 -0.21 -174 -0.03 -0.02 -0.02 -0.02 -16.5 -12.4 -15.2 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 - -0.01 -0.01 -0.01 - -0.01 -0.01 -0.01

ROE %

145.85 -277.89 -217.08 -268.55 -290.38 -185.51 -116.96 -52.29 -59.34 -44.56 -35.23 -20.93 -40.62 -53.27 -60.73 -55.29 -65.92 -56.86 -54.97 -29.45 -282.41 -524.73 -650.77 -547.95 -578.62 -356.33 -243.25 -60.20 -76.83 -65.22 -64.18 -81.92 -80.13 -76.44 -64.34 -55.68 -51.55 -43.88 -40.92 -30.30 -36.10 -57.52 -57.95 -68.27 -93.49 -106.09 -136.27 -106.76 -124.04 -99.60 -76.37 -53.49 -17.28 -15.87 -20.33

ROA %

-350.13 -342.51 -370.89 -176.11 -195.18 -150.53 -99.95 -47.34 -54.08 -41.76 -33.25 -19.95 -37.96 -49.23 -55.81 -50.57 -60.47 -52.35 -50.80 -27.41 -148.47 -259.63 -314.69 -269.01 -296.94 -203.81 -160.32 -54.82 -66.06 -51.01 -44.52 -55.35 -57.66 -58.81 -53.36 -50.83 -47.60 -41.00 -38.73 -29.20 -34.42 -54.44 -54.65 -64.31 -84.62 -93.06 -118.26 -91.76 -107.35 -87.08 -67.79 -48.26 -15.59 -14.32 -18.34

ROCE %

145.64 -354.04 -202.84 -271.97 -293.86 -186.01 -117.32 -52.37 -59.42 -44.57 -35.23 -20.93 -40.64 -53.30 -60.78 -55.45 -66.22 -57.29 -55.53 -29.78 -282.82 -525.09 -651.13 -548.44 -579.13 -356.79 -247.76 -84.26 -104.50 -110.14 -104.91 -102.85 -97.51 -76.58 -64.50 -55.87 -51.71 -44.05 -41.08 -30.45 -36.24 -57.64 -58.05 -68.34 -93.53 -106.11 -136.26 -106.77 -124.08 -99.66 -76.47 -53.55 -17.31 -15.91 -20.33

Current Ratio

0.8 1.3 0.4 1.2 2.0 4.4 5.6 8.9 7.9 14.1 13.7 23.9 23.0 22.7 19.2 11.7 11.7 11.7 11.7 14.4 14.4 14.4 14.4 1.9 1.9 1.9 2.1 11.2 11.2 11.2 11.2 3.1 3.1 3.1 3.1 11.5 11.5 11.5 11.5 27.5 27.5 27.5 27.5 17.2 17.2 17.2 17.2 7.1 7.1 7.1 7.1 10.2 10.2 10.2 10.2

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD